News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

The Economist Events’ War On Cancer 2016

11/30/2016 10:41:02 AM

Exploring solutions to the mismatch in progress and delivery in cancer care

Tweet your questions ahead of the event via @EconomistEvents #WaronCancer

30 November, 2016: The Economist Events’ second annual War on Cancer 2016 will bring together over 150 global leaders in oncology to explore solutions to the mismatch in progress and delivery in cancer care across Europe. The forum will discuss innovative approaches to cancer prevention and treatment, solutions to overcome shortcomings in delivery and examples of best practices and opportunities for cross-sectoral collaboration.

The forum will be held on Tuesday, December 6th 2016 at the Marriott Grosvenor Square, London, from 8:00am to 5:40pm.

Mary-Jane Elliott, Managing Partner at Consilium Strategic Communications, the Official PR Agency for The Economist Events’ War on Cancer forum, commented: “Healthcare systems around the world are facing a range of challenges, many of which have the potential to directly impact how cancer will be treated in the future. This forum will bring together leading oncologists and other key stakeholders to discuss how we can ensure health systems remain sustainable in order to deliver promising new technologies and treatments in the fight against cancer. Consilium is very proud to support the event again for this, its second year. We are looking forward to the forum, the panels and the lively discussions it will provoke."

Innovative approaches to cancer treatment, prevention and care are emerging at an unprecedented rate. However, the policies and systems in place to deliver these advancements to people are lagging behind. Currently in the UK to get a new medicine from the research lab to patients it takes an average of 10 years and £1 billion. Whether we are fighting cancer with novel therapies or adopting the latest preventative guidance, we must ensure that our systems are up to the task of delivering progress. How do we scale the knowledge and capability in oncology that we already have and prepare for what’s coming?

Key speakers at the summit include:

• Matti Aapro, Board Member, European Cancer Organisation

• Cary Adams, Chief Executive Officer, Union for International Cancer Control

• Tit Albreht, Coordinator, Cancer Control Joint Action (CanCon); Head, National Institute of Public Health of Slovenia

• Kathi Apostolidis, Vice-president, European Cancer Patient Coalition (ECPC); President of Executive Committee, Hellenic Cancer Federation – ELL.O.K

• Frauke Becker, Research Associate, Institute of Health and Society, Newcastle University

• John Bell, Regius Professor of Medicine, University of Oxford; Chairman, Office for Strategic Coordination of Health Research (OSCHR)

• Jurgi Camblong, Chief Executive Officer and Co-founder, Sophia Genetics

• Josep Figueras, Director, European Observatory on Health Systems and Policies; Head, World Health Organization European Centre on Health Policy

• George Freeman, Member of Parliament for Mid Norfolk and Chair, Prime Minister’s Policy Board

• David Khayat, Head of the Department of Oncology, Pitié-Salpêtrière Hospital and Professor of Oncology, University Pierre and Marie Curie

• Bryony Kimmings, Creator of the musical ‘A Pacifist’s Guide to the War on Cancer’

• Jane Maher, Chief Medical Officer, Macmillan Cancer Support

• Lydia Makaroff, Director, European Cancer Patient Coalition

• Mahiben Maruthappu, Co-founder, NHS Innovation Accelerator

• Maya Martinez – Davis, Senior Vice-president, Global Head of Oncology Franchise, Merck KGaA

• Vivek Muthu, Chair, Economist Intelligence Unit Healthcare

• Luca Pani, CHMP-SAWP, Member European Medicines Agency (EMA); Department of Psychiatry and Behavioral Sciences, University of Miami

• Annie Pannelay, Healthcare Principal, Economist Intelligence Unit

• Terje Peetso, Policy Officer, Directorate-General Communications Networks, Content and Technology, European Commission

• Andreas Penk, Regional President Oncology, International Developed Markets, Pfizer

• Jem Rashbass, National Director for Disease Registration, Public Health England

• Gunnar Saeter, Professor and Head of Institute, Institute for Cancer Research - Olso University Hospital

• Katherine Smith, Reader- Global Public Health Unit, University of Edinburgh

• Zhen Su, Vice-president, US Oncology Medical Affairs, EMD Serono

• Richard Sullivan, Professor of Cancer and Global Health, King’s College London; Director, Institute of Cancer Policy

• Frans van Houten, Chief Executive and Chairman, Philips

• Paul Workman, Chief Executive Officer and President, The Institute of Cancer Research London; Harrap Professor of Pharmacology and Therapeutics

For more information and to view the full programme please visit:

Read at

comments powered by Disqus